Ann Catherine Childress, MD
Center for Psychiatry and Behavioral Medicine, Inc. and
- Advisory Board: Pfizer Inc.; Shionogi & Co., Ltd.
- Consultant: Ironshore Inc.; NextWave Pharmaceuticals; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals, Inc.
- Research Support: Arbor Pharmaceuticals ; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Ironshore Inc.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Neos Therapeutics, Inc.; Neurovance; NextWave Pharmaceuticals; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Sepracor Inc; Shionogi & Co., Ltd.; Shire Pharmaceuticals, Inc.; Sunovion Pharmaceuticals Inc.; Theravance
- Speakers Bureau: Bristol-Myers Squibb; Novartis Pharmaceutical Corporation; Pfizer Inc.; Shionogi & Co., Ltd.; Shire Pharmaceuticals, Inc.
